Oral treatment of acute pyelonephritis: when, with which antimicrobial agent and for how long? Carlos Pigrau; Laura Escolà-Vergé;

ESBL-producing-multidrug resistant E. coli population from urinary tract infections is less diverse than non-ESBL-multidrug resistant population David M. Arana; Aída Sánchez; Verónica Bautista; Jesús Oteo-Iglesias; Juan-Ignacio Alós;

Optimizing the management of Pseudomonas aeruginosa infections with tools for the detection of resistance mechanisms and pharmacokinetic/pharmacodynamic (PK/PD) analysis Carlos Juan;